T. Ciccarone

HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins.

D. Veber, R. Freidinger, V. Garsky, 1988, Biochemical and biophysical research communications.

Non-thiol 3-aminomethylbenzamide inhibitors of farnesyl-protein transferase.

T. Ciccarone, N. Kohl, J. Gibbs, 1999, Bioorganic & Medicinal Chemistry Letters.

Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agents.

A. W. Shaw, T. Ciccarone, L. Beese, 2003, Journal of medicinal chemistry.

Diaryl ether inhibitors of farnesyl-protein transferase.

A. W. Shaw, T. Ciccarone, J. Davide, 1997, Bioorganic & medicinal chemistry letters.

2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferase.

T. Ciccarone, A. Kral, J. Davide, 1996, Journal of medicinal chemistry.

5-chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.

W. Greenlee, T. Ciccarone, J. Condra, 1993, Journal of medicinal chemistry.

5‐Chloro‐3‐(phenylsulfonyl)indole‐2‐carboxamide: A Novel, Non‐ Nucleoside Inhibitor of HIV‐1 Reverse Transcriptase.

W. Greenlee, P. Anderson, T. Ciccarone, 1994 .

Chemical synthesis and enzymatic activity of a 99-residue peptide with a sequence proposed for the human immunodeficiency virus protease.

P. Darke, R. Nutt, S. Brady, 1988, Proceedings of the National Academy of Sciences of the United States of America.